These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12018783)

  • 1. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.
    Hauck WW; Shaikh R
    J Biopharm Stat; 2001 Nov; 11(4):335-46. PubMed ID: 12018783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using tolerance intervals for assessment of pharmaceutical quality.
    Dong X; Tsong Y; Shen M; Zhong J
    J Biopharm Stat; 2015; 25(2):317-27. PubMed ID: 25356617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics.
    Brannath W; Bretz F; Maurer W; Sarkar S
    Biom J; 2009 Dec; 51(6):885-98. PubMed ID: 20014203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size determination for confidence intervals of interaction effects in moderated multiple regression with continuous predictor and moderator variables.
    Shieh G
    Behav Res Methods; 2010 Aug; 42(3):824-35. PubMed ID: 20805605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approximate sample size formulas for the two-sample trimmed mean test with unequal variances.
    Luh WM; Guo JH
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):137-46. PubMed ID: 17535584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-sided tolerance intervals for balanced and unbalanced random effects models.
    Hoffman D; Kringle R
    J Biopharm Stat; 2005; 15(2):283-93. PubMed ID: 15796296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptance criteria for method equivalency assessments.
    Chatfield MJ; Borman PJ
    Anal Chem; 2009 Dec; 81(24):9841-8. PubMed ID: 19925004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parametric two-stage sequential quality assurance test of dose content uniformity.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(1):143-57. PubMed ID: 17219760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some optimal and non-optimal two-stage designs using an alpha-spending function.
    Patel HI
    Stat Med; 1996 Aug; 15(16):1739-45. PubMed ID: 8870156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical considerations in setting product specifications.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.
    Liu GF; Zhu GR; Cui L
    Stat Med; 2008 Feb; 27(4):584-96. PubMed ID: 17634972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum sample size allocation to minimize cost or maximize power for the two-sample trimmed mean test.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):283-98. PubMed ID: 18157920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of the probability of passing the USP dissolution test.
    Wang H
    J Biopharm Stat; 2007; 17(3):407-13. PubMed ID: 17479390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical inference of risk difference in K correlated 2 x 2 tables with structural zero.
    Wang SF; Tang NS; Zhang B; Wang XR
    Pharm Stat; 2009; 8(4):317-32. PubMed ID: 19152229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
    Montes RO; Burdick RK; Leblond DJ
    PDA J Pharm Sci Technol; 2019; 73(1):39-59. PubMed ID: 30361286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations.
    Senderak ET
    Drug Dev Ind Pharm; 2009 Jun; 35(6):735-7. PubMed ID: 19514989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.